Characterization of the Fluorescent Spectra and Intensity of Dabigatran and Dabigatran Etexilate: Application to HPLC Analysis with Fluorescent Detection-Reference-Cited by-同舟云学术

Characterization of the Fluorescent Spectra and Intensity of Dabigatran and Dabigatran Etexilate: Application to HPLC Analysis with Fluorescent Detection

Published:2016-07-29 Issue:9 Volume:54 Page:1648-1651
ISSN:0021-9665
Container-title:Journal of Chromatographic Science
language:en
Short-container-title:J Chromatogr Sci

Author:

Schwertner Harvey A.,Stankus John J.

Publisher

Oxford University Press (OUP)

Subject

General Medicine,Analytical Chemistry

Link

http://academic.oup.com/chromsci/article-pdf/54/9/1648/6609802/bmw122.pdf

Reference13 articles.

1. The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

2. New oral antithrombotics: a need for laboratory monitoring. Against

3. The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans

4. Pharmacokinetic and Clinical Implications of Dabigatran Use in Severe Renal Impairment for Stroke Prevention in Nonvalvular Atrial Fibrillation

5. Validated stability-indicating high performance liquid chromatographic assay method for the determination of dabigatran etexilate mesylate;Shelke;Research Journal of Pharmaceutical, Biological, and Chemical Science,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of a Quantification Method for Direct Oral Anticoagulants from Capillary Blood Using Volumetric Absorptive Microsampling and Online Spe-Lc-Ms;2024

2. Development and validation of a ultraperformance liquid chromatography–tandem mass spectrometry method for quantifying free and total dabigatran in human plasma: An application for a bioequivalence study;Biomedical Chromatography;2022-05-06

3. A chemometric comparison of different models in fluorescence analysis of dabigatran etexilate and dabigatran;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2021-02

4. DOAC plasma levels measured by chromogenic anti‐Xa assays and HPLC‐UV in apixaban‐ and rivaroxaban‐treated patients from the START‐Register;International Journal of Laboratory Hematology;2020-02-10

5. An improved extraction protocol for therapeutic dabigatran monitoring using HPLC-MS/MS;Journal of Chromatography B;2019-11